POLYMED - Swing Trade Analysis with AI Signals
Back to List📊 Swing Trade Rating: 3.5
| Stock Code | POLYMED | Market Cap | 15,941 Cr. | Current Price | 1,573 ₹ | High / Low | 2,318 ₹ |
| Stock P/E | 46.7 | Book Value | 301 ₹ | Dividend Yield | 0.22 % | ROCE | 15.0 % |
| ROE | 11.8 % | Face Value | 5.00 ₹ | DMA 50 | 1,469 ₹ | DMA 200 | 1,642 ₹ |
| Chg in FII Hold | -3.49 % | Chg in DII Hold | 1.76 % | PAT Qtr | 80.6 Cr. | PAT Prev Qtr | 83.4 Cr. |
| RSI | 59.9 | MACD | 14.9 | Volume | 1,03,403 | Avg Vol 1Wk | 1,21,315 |
| Low price | 1,182 ₹ | High price | 2,318 ₹ | PEG Ratio | 1.82 | Debt to equity | 0.08 |
| 52w Index | 34.4 % | Qtr Profit Var | -6.97 % | EPS | 33.2 ₹ | Industry PE | 36.9 |
Analysis: POLYMED shows moderate swing trade potential with fair fundamentals and improving technicals. The RSI at 59.9 indicates bullish momentum, while MACD at 14.9 confirms positive crossover. Current price (1,573 ₹) is above the 50 DMA (1,469 ₹) but below the 200 DMA (1,642 ₹), reflecting short-term strength but medium-term weakness. Valuation is stretched with a P/E of 46.7 compared to industry average of 36.9, and PEG ratio at 1.82 suggests reasonable growth valuation. Fundamentals are modest with ROCE at 15.0% and ROE at 11.8%. PAT declined sequentially (₹83.4 Cr → ₹80.6 Cr), showing margin pressure despite strong EPS (₹33.2).
Optimal Entry Price: Around 1,450–1,470 ₹, near support levels.
Exit Strategy: If already holding, consider profit booking near 1,600–1,620 ₹ resistance (200 DMA zone), or trail stop-loss below 1,430 ₹.
✅ Positive
- 📈 EPS of ₹33.2 indicates earnings stability.
- 📊 DII holding increased (+1.76%), showing domestic institutional support.
- 📉 Debt-to-equity ratio at 0.08, reflecting financial stability.
- 💰 Dividend yield of 0.22% provides steady returns.
⚠️ Limitation
- ⚠️ Current price below 200 DMA, showing weak long-term momentum.
- 📉 ROCE (15.0%) and ROE (11.8%) are moderate compared to peers.
- 📊 PAT declined sequentially, reflecting margin pressure.
📉 Company Negative News
- 📉 PAT declined from ₹83.4 Cr. to ₹80.6 Cr.
- ⚠️ FII holding decreased (-3.49%), showing reduced foreign investor confidence.
📈 Company Positive News
- 📈 DII holding increased (+1.76%), showing domestic institutional confidence.
- 📊 EPS positive at ₹33.2, signaling operational stability.
🏭 Industry
- 📊 Industry P/E at 36.9, lower than POLYMED’s valuation, suggesting peers may be more attractively priced.
- ⚕️ Medical devices and healthcare industry benefits from rising demand but faces regulatory and cost challenges.
🔎 Conclusion
⚖️ POLYMED offers moderate swing trade potential with fair fundamentals but weak long-term technicals. Entry near 1,450–1,470 ₹ with strict stop-losses is advisable. If already holding, exit near 1,600–1,620 ₹ unless volume-driven breakout occurs.
Would you like me to also prepare a peer comparison to evaluate relative opportunities in the medical devices and healthcare sector?